Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OFFICE OF INDUSTRY AND TRADE RELATIONS TO BE HEADED BY JACK MARTIN

Executive Summary

FDA OFFICE OF INDUSTRY AND TRADE RELATIONS TO BE HEADED BY JACK MARTIN, special assistant to the commissioner and former associate commissioner for public affairs under FDA Commissioner Frank Young. Other office staff will include Mary Ann Danello, currently special assistant to the commissioner for science, and public affairs staffer Elizabeth Wright. The formation of the office was announced by FDA Acting Commissioner Benson at the May 17 meeting of the FDA blue ribbon panel. FDA will send out letters next month to regulated industry, including individual companies as well as trade associations, announcing the formal establishment of the office and detailing the office's responsibilities. The Office of Industry and Trade Relations will be a source for the industry of information on FDA regulations, policy, and legislation, FDA noted. Currently there is no single source of such information at FDA. The office will also disseminate information from the industry to the commissioner and the centers. However, the office will not serve as ombudsman to companies, FDA said. The role of the office is not to field complaints or solve problems between FDA and companies, but to serve as an "out basket" of agency information, FDA remarked. FDA plans to send staff from the office to trade shows and association meetings to promote better relations with industry. In addition, the office will concentrate on developing better communications with small businesses and insuring that information on FDA policy is reaches them.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS017452

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel